DBCO-PEG8-GGFG-DXD
PG-20161-82975
Product information
- Catalog No.
- PG-20161-82975
- Product Name
- DBCO-PEG8-GGFG-DXD
- CAS No.
- Not specified
- Molecular Formula
- C80H95FN10O21
- Molecular Weight
- 1551.7
- Purity
- 95%
- Storage
- -20°C
- Shipping
- Ambient Temperature
- Documents
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
Packaging & pricing
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-82975 | 1 MG | Inquiry | In stock | |
| PG-20161-82975 | 5 MG | Inquiry | In stock | |
| PG-20161-82975 | 10 MG | Inquiry | In stock | |
| PG-20161-82975 | 25 MG | Inquiry | In stock |
Final pricing, package availability and delivery are confirmed with your quotation.
General Information
- Product Name
- DBCO-PEG8-GGFG-DXD
- CAS No.
- Not specified
- Synonyms
- Not specified
- Molecular Formula
- C80H95FN10O21
- Molecular Weight
- 1551.7
- Appearance
- Not specified
- Solubility
- Not specified
- Description
DBCO-PEG8-GGFG-DXD is a linker-payload construct for antibody–drug conjugate research. A DBCO handle enables copper-free SPAAC conjugation with azide-modified antibodies, while an 8-unit PEG spacer supports aqueous solubility. The construct also incorporates a protease-cleavable GGFG tetrapeptide linker.
The DXD payload is an exatecan derivative that inhibits DNA topoisomerase I. This combination places the compound among cleavable ADC linker-payloads for investigating intracellular payload release. The listed purity is 95%, and storage is specified at -20°C.